Lexapro (escitalopram) withdrawal symptoms typically begin within two to four days after stopping or sharply reducing the dose, peak somewhere around the second or third week, and resolve within a few weeks for most people. That textbook timeline, though, understates the range. A substantial minority of people experience symptoms that drag on for months, and a smaller group deals with them for over a year. The duration depends on how long you took the medication, your dose, how quickly you tapered, and individual biological factors that are still poorly understood.
Why Symptoms Start When They Do
Escitalopram has an elimination half-life of roughly 27 to 33 hours, meaning the drug’s blood levels drop by half about every day and a half after your last dose.1PubMed. The clinical pharmacokinetics of escitalopram After stopping, it takes several half-lives for the drug to effectively clear your system. By around day three to five, levels are low enough that your brain’s serotonin signaling is substantially different from what it had adapted to. That is when withdrawal symptoms tend to appear. The brain has spent weeks, months, or years adjusting its serotonin receptors to operate with the drug on board, and when the drug leaves faster than those receptors can readjust, the mismatch produces symptoms.2PubMed Central. Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case report
Compare this to paroxetine (Paxil), which has a much shorter half-life and is notorious for withdrawal hitting within a day or two. Escitalopram’s slightly longer half-life gives a bit more of a runway, which is one reason some clinicians consider it somewhat easier to discontinue than paroxetine or venlafaxine. But “somewhat easier” does not mean easy. A 2024 meta-analysis found that escitalopram was specifically associated with higher frequencies of discontinuation symptoms compared to several other antidepressants.3The Lancet Psychiatry. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis
The Week-by-Week Picture
There is no single official withdrawal calendar, because the experience varies considerably. But pulling together the available research, a general pattern emerges for people stopping escitalopram after several months or more of use.
During the first week, the most common early symptoms include dizziness, nausea, headaches, irritability, and a general flu-like feeling. Sleep disturbances often show up quickly too, ranging from insomnia to unusually vivid or disturbing dreams. Many people report feeling unusually anxious or emotionally volatile in ways that feel different from their original depression or anxiety.
During weeks two and three, symptoms often intensify before they improve. One study that tracked the time course of withdrawal found that discontinuation symptom scores peaked at around day 22 after stopping.4PubMed Central. Do withdrawal symptoms predict depression relapse after antidepressant cessation? This is when brain zaps, the strange electrical-shock sensations in the head that have become a hallmark of SSRI withdrawal, tend to be at their worst. Fatigue, difficulty concentrating, and emotional blunting or sudden crying spells are also commonly reported in this window.
By weeks four through six, most people who are going to have a straightforward withdrawal course start noticing improvement. Symptoms become less frequent and less intense. Brain zaps may linger but occur less often. Sleep starts normalizing. For a significant number of people, though, this is not where the story ends.
When Withdrawal Lasts Longer Than Expected
Older clinical guidelines often stated that antidepressant withdrawal is mild, self-limiting, and resolves within one to two weeks. The research paints a different picture. A systematic review found that a significant proportion of people experience withdrawal lasting well beyond two weeks, and that durations of several months are not uncommon. The four studies in that review that calculated average duration found wildly different numbers depending on the population studied: 5 days, 10 days, 43 days, and 79 weeks.5PubMed. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? That spread reflects real variation, not sloppy science.
A 2025 survey of patients in primary care found that about one in five reported withdrawal symptoms lasting more than three months, and one in ten reported symptoms persisting for over a year.6PubMed. Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services The single strongest predictor of prolonged withdrawal was how long you had been taking the antidepressant. People who had been on the medication for more than two years were roughly ten times more likely to develop a withdrawal syndrome than those who had taken it for less than six months, and they were about five times more likely to rate their symptoms as severe.7PubMed. Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services
This protracted withdrawal, sometimes called post-acute withdrawal syndrome, can include waves of anxiety and depression, continued brain zaps, fatigue, cognitive fog, and sleep disruption that come and go unpredictably. An analysis of consumer narratives about protracted withdrawal found that emotional symptoms like anxiety, depression, emerging suicidality, and agitation were reported by about 81% of those affected. Somatic symptoms including headache, fatigue, dizziness, brain zaps, visual changes, and muscle aches were reported by roughly 75%.8PubMed Central. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum
What the Symptoms Actually Feel Like
Withdrawal from Lexapro involves both physical and emotional symptoms, and people are often caught off guard by how physical the experience can be. Common physical symptoms include dizziness, nausea, sweating, headaches, tremor, diarrhea, joint pain, and fatigue. Qualitative research with people going through SSRI withdrawal found that every participant reported physical side effects, and these affected not just general comfort but academic performance and social life.9PubMed Central. The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
Brain zaps deserve special mention because they are so distinctive and so distressing. People describe them as brief electrical jolts or shock-like sensations originating inside the head, sometimes accompanied by a flash of disorientation or a momentary lapse in awareness. They are often triggered by eye movements. From the outside they sound bizarre; from the inside they can be genuinely frightening, especially because most people have never heard of them before they happen.10Annals of Indian Psychiatry. Brain Zaps during Selective Serotonin Reuptake Inhibitor Withdrawal: An Overlooked Phenomenon in Psychiatry Taking another dose of the SSRI typically stops them almost immediately, which strongly suggests they are caused by the drop in serotonin transporter blockade rather than by any structural problem in the brain.
On the emotional side, heightened anxiety, sudden mood swings, irritability, and crying spells are common. Some people describe a strange emotional numbness alternating with overwhelming sensitivity. Research into the distinctive nature of antidepressant withdrawal found that the syndrome includes a range of emotional and physical symptoms that can be severe, prolonged, and have a profound impact on daily functioning.11Journal of Affective Disorders Reports. The nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS)
Withdrawal Versus Relapse
One of the trickiest parts of stopping Lexapro is figuring out whether the sadness or anxiety you feel is withdrawal or a return of the original condition. The two can look remarkably similar, and this confusion has real consequences. When withdrawal symptoms get mistaken for relapse, the typical response is to restart the antidepressant, which can lead to years of unnecessary medication use.12The Lancet Psychiatry. Tapering of SSRI treatment to minimise discontinuation symptoms
There are a few clues that help tell the difference. Timing is the biggest one. Withdrawal symptoms tend to start within days of stopping or reducing the dose and peak earlier. In one study, withdrawal symptom scores peaked around day 22, while depression symptom scores peaked around day 28.13PubMed Central. Do withdrawal symptoms predict depression relapse after antidepressant cessation? That is not a huge gap, but it is consistent with the idea that withdrawal hits first and fades, while relapse builds more gradually.
Symptom type matters too. Brain zaps, electric shock sensations, dizziness, and flu-like symptoms are almost never features of depression or anxiety on their own. If you are experiencing those alongside low mood, withdrawal is the more likely explanation, at least initially. On the other hand, if sadness and hopelessness build steadily over weeks and remain after the physical symptoms have cleared, that looks more like a return of the underlying condition. If you are unsure, the safest approach is to discuss the pattern with your prescriber rather than making changes to your medication on your own.
Why Tapering Slowly Matters More Than You Think
The standard medical advice to “gradually taper” your antidepressant is correct but often vaguely applied. Many prescribers cut the dose in half every week or two until reaching zero. Research into how SSRIs actually work in the brain suggests this approach is too aggressive, especially at lower doses.
The issue is that the relationship between dose and the drug’s actual effect on serotonin signaling is not a straight line. At lower doses, each milligram matters much more. Reducing from 20 mg to 10 mg cuts the drug’s effect on serotonin transporter blockade by a relatively small amount, because you are already near a plateau of effect at therapeutic doses. But dropping from 5 mg to 2.5 mg, or from 2.5 mg to zero, produces a proportionally much larger disruption in serotonin signaling.14Molecular Psychiatry. The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review This is why many people feel fine tapering from higher doses but hit a wall when they try to make the final jump to zero.
The implication is that tapering should follow a hyperbolic curve: bigger steps at the top, progressively smaller steps as you approach zero. Instead of going 20 → 10 → 5 → 0, a gentler taper might look something like 20 → 15 → 10 → 7.5 → 5 → 3 → 2 → 1 → 0.5 → 0, with each step held for several weeks. Getting those tiny doses may require liquid formulations or compounding pharmacies, since Lexapro tablets don’t easily split into fractions below 5 mg. This hyperbolic tapering approach has gained increasing recognition in the psychiatric literature as a way to reduce withdrawal severity.15The Lancet Psychiatry. Tapering of SSRI treatment to minimise discontinuation symptoms
There is, however, some emerging nuance. A 2026 preprint suggested that the relationship between serotonin transporter blockade and actual serotonin concentrations in the brain may itself be nonlinear, meaning the neat logic of hyperbolic tapering might need further refinement.16medRxiv. The relationship between serotonin transporter occupancy and extracellular serotonin concentration is hyperbolic, not linear: implications for safely tapering antidepressants The practical takeaway for now is still the same: slower is better, and the final stretch toward zero needs to be the slowest part.
How Common and How Severe
You might wonder whether withdrawal is really something most Lexapro users need to worry about, or whether it only happens to a small unlucky minority. The honest answer is somewhere in between, and the research community has been arguing about the exact numbers for years.
A large 2024 meta-analysis in The Lancet Psychiatry estimated that about 31% of people experience at least one discontinuation symptom after stopping an antidepressant. That same analysis found the rate of severe symptoms was around 3%.17The Lancet Psychiatry. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis However, another review that focused specifically on SSRIs estimated that roughly half of all people who stop an SSRI experience some form of discontinuation syndrome.18PubMed Central. Estimating Risk of Antidepressant Withdrawal from a Review of Published Data The discrepancy comes down partly to how withdrawal is defined and measured, and partly to whether the analysis accounts for the placebo-discontinuation effect (about 17% of people in clinical trials experience symptoms after stopping a placebo, suggesting some symptoms are driven by expectation or the nocebo effect).19The Lancet Psychiatry. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis
Regardless of whether you land on 31% or 50%, withdrawal is common enough that anyone stopping Lexapro should at least be aware of the possibility and have a tapering plan.
The Gap in Clinical Guidelines
If you have ever felt frustrated by your doctor’s vague advice about tapering, you are not alone, and it is not entirely your doctor’s fault. A systematic review of 21 clinical practice guidelines on antidepressant discontinuation found that while most recommended tapering “gradually or slowly,” not a single one provided specific guidance on dose reduction schedules, how to distinguish withdrawal from relapse, or how to manage withdrawal symptoms once they appear.20PubMed Central. Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review The overall quality of these guidelines was rated as low. Clinicians are, in many cases, improvising based on clinical experience because the formal guidance has not caught up with the research.
This gap matters. It means the quality of your withdrawal experience can depend heavily on whether your prescriber happens to be up to date on the tapering literature. If you are told to simply halve your dose for a week and then stop, that is an outdated approach. It is reasonable to ask about a slower, hyperbolic taper, and to request a liquid formulation or compounding if you need doses below what tablets can provide.
Psychological Support During Tapering
Tapering is not purely a pharmaceutical problem. The anxiety of stopping a medication that has been keeping you stable can itself trigger distress, and many people find themselves in a cycle of worry about whether each bad day signals relapse. Cognitive behavioral therapy has shown real promise in this context. Studies that combined gradual tapering with CBT reported antidepressant cessation rates of 40% to 95%, and at two years, the risk of relapse was substantially lower for people who received therapy alongside tapering compared to those who tapered with clinical management alone.21The Annals of Family Medicine. Managing Antidepressant Discontinuation: A Systematic Review
Mindfulness-based cognitive therapy also appears helpful. In studies comparing mindfulness-based therapy with tapering versus simply staying on the antidepressant, relapse rates were similar between the two approaches, suggesting that mindfulness could serve as an alternative maintenance strategy for some people.22The Annals of Family Medicine. Managing Antidepressant Discontinuation: A Systematic Review These therapies are resource-intensive, so they may not be accessible to everyone, but they are worth exploring if you have access.
Factors That Raise Your Risk
Not everyone who stops Lexapro will have a difficult time. Several factors make withdrawal more likely or more severe:
- Duration of use: The longer you have been taking escitalopram, the more your brain has adapted. People on it for more than two years have dramatically higher odds of both experiencing withdrawal and rating it as severe.23PubMed. Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services
- Higher doses: Starting from a higher dose means a larger overall adjustment for the brain, though the hyperbolic dose-effect relationship means even low-dose users can struggle if they taper too quickly at the end.
- Speed of taper: Abrupt discontinuation is the single most controllable risk factor. Even gradual tapering can still produce symptoms, but slow tapering significantly reduces the chance of severe ones.24Psychotherapy and Psychosomatics. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review
- Individual metabolism: Escitalopram is primarily metabolized by a liver enzyme called CYP2C19. People who are poor metabolizers of this enzyme may clear the drug more slowly, which can complicate both treatment and withdrawal in unexpected ways.25PubMed Central. Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case report
- Previous withdrawal experiences: People who have had difficulty stopping an antidepressant before are more likely to have trouble again, though this may partly reflect the same underlying biological susceptibility.
Genetic Metabolism and Unusual Reactions
The CYP2C19 enzyme factor is worth expanding on because it explains some of the more extreme withdrawal stories. Roughly 2-5% of people of European descent and a larger percentage of people of East Asian descent are poor metabolizers of CYP2C19, meaning their bodies break down escitalopram much more slowly than average. For these individuals, the drug effectively builds up to higher levels at standard doses, and the brain adapts to those higher levels. When the medication is stopped, even what looks like a modest dose reduction on paper can produce an outsized drop in actual drug exposure. A case report described a CYP2C19 poor metabolizer who developed protracted withdrawal syndrome after stopping escitalopram, with symptoms extending well beyond the typical timeline.26PubMed Central. Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case report
Pharmacogenomic testing, which identifies your CYP2C19 status through a simple cheek swab, is increasingly available and can inform tapering decisions. If you are a poor metabolizer, your prescriber may recommend an even slower taper than usual, and starting from a lower dose to begin with. This is the kind of personalized information that can make the difference between a manageable taper and a miserable one.